Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Finding the right credit card with the best travel rewards program can enhance your travel experiences. Explore top options available.
27,015 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A 65-agent Texas team leaves Fathom Realty to join The Real Brokerage, citing technology and revenue sharing as key d...
A university dean warns that AI's push for efficiency could erase entry-level roles for young workers, even as they d...
SpaceX's IPO excitement gave way to a pullback, leaving investors wondering about future gains. This guide breaks dow...
What happened in Designer Brands (DBI) 2025 earnings, and what it means for investors in 2026. This guide breaks down...
As markets swing and tax rules shift, households with a $450K+ 401K are weighing year-end charity moves. A Donor-Advi...
As retail faces slower discretionary spend, Walmart doubles down on automation, ads, and marketplace scale, while Cos...
A Crinetics director sells 5,000 shares as the stock dips. This guide breaks down what insider moves really mean for ...
A hidden Medicare surcharge tied to income can lift monthly costs by hundreds for pre-retirees. Here’s how IRMAA work...
The United States still holds a 714-million-barrel strategic reserve capacity, a focal point for policy debates and e...
Keystone reveals a sizable new stake in the IDEF defense ETF, signaling growing investor interest in defense and indu...
As AI pushes data growth, memory stocks grab the spotlight. This guide explains why don’t forget about western—Wester...